The Current Ratio as of November 2024 (TTM) for Intellia Therapeutics, Inc. (NTLA) is 6.73

According to Intellia Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.73. This represents a change of -14.92% compared to the average of 7.91 of the last 4 quarters.

Intellia Therapeutics, Inc. (NTLA) Historical Current Ratio (quarterly & annually)

How has NTLA Current Ratio performed in the past?

The mean historical Current Ratio of Intellia Therapeutics, Inc. over the last ten years is 8.19. The current 6.73 Current Ratio has changed 8.12% with respect to the historical average. Over the past ten years (40 quarters), NTLA's Current Ratio was at its highest in in the June 2016 quarter at 14.01. The Current Ratio was at its lowest in in the March 2015 quarter at 0.

Intellia Therapeutics, Inc. (NTLA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Intellia Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Intellia Therapeutics, Inc. (NTLA) Average Current Ratio

How has NTLA Current Ratio performed in the past?

The current Current Ratio of Intellia Therapeutics, Inc. (NTLA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Intellia Therapeutics, Inc. (NTLA) Current Ratio vs. Peers

How is NTLA’s Current Ratio compared to its peers?

Intellia Therapeutics, Inc.’s Current Ratio is greater than Editas Medicine, Inc. (3.75), less than Caribou Biosciences, Inc. (7.38), less than CRISPR Therapeutics AG (21.64), less than Verve Therapeutics, Inc. (13.05), greater than Beam Therapeutics Inc. (5.69), less than Fate Therapeutics, Inc. (8.29), greater than Vertex Pharmaceuticals Incorporated (2.47), greater than Ginkgo Bioworks Holdings, Inc. (5.79), greater than Prime Medicine, Inc. (6.50), greater than Sana Biotechnology, Inc. (4.47),

Build a custom stock screener for Intellia Therapeutics, Inc. (NTLA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Intellia Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Intellia Therapeutics, Inc. (NTLA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Intellia Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.